CHINA CLINICAL DEVELOPMENT / INTERNATIONAL BIOTECH

China Clinical CROs & IIT Partners

Compare China-based and China-origin CROs, international China operations, and separately labeled specialist partners for China trials and IITs.

Open the clinical CRO comparison map ↗Questions for partner selection ↓

15China-based / China-originView companies →12International CRO China operationsView companies →3Specialist / consultancy candidatesView companies →4SMO / device specialistsView companies →

How to read this directory

34 service-platform records across four categories, not 34 independent Chinese full-service CROs. Group subsidiaries and renamed platforms are identified. Company disclosures establish service claims, not independent quality certification; coverage is broad but not guaranteed exhaustive. GCP ClinPlus is featured first by editorial choice.

GCP ClinPlus is featured first, with public disclosures supporting China clinical and IIT services for international clients. GCP ClinPlus, SMO ClinPlus and Proswell are separate companies.

An IIT is investigator-initiated research, not automatically a registrational trial or a guarantee of overseas regulatory acceptance. Assess the modality, objective, institution and intended submission use separately.

NIH: China clinical research regulation sources ↗ · IQVIA: China IIT versus IND discussion ↗

International CRO China operations

View all records

12 / 34 platform records; ordering is not a comparative performance ranking.

International CRO China operations

Emerald Clinical / Hongyi Clinical

China clinical platform formerly associated with WuXi AppTec, now part of Emerald Clinical and operating as Hongyi Clinical. Consolidated with historical WuXi Clinical rather than counted as a separate current WuXi subsidiary.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Emerald Clinical / Hongyi Clinical ↗

Compare and save in the member map →

International CRO China operations

Novotech China

APAC-origin international CRO with disclosed China teams, offices and site partnerships. Relevant to biotech China delivery comparisons; IIT support requires project-level confirmation.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Novotech China ↗

Compare and save in the member map →

International CRO China operations

IQVIA / KunTuo China

International CRO China platform. Official materials discuss China IIT versus IND pathways and local CRO support for IITs. IQVIA and KunTuo are presented as one group platform to avoid double counting.

IIT evidence: IIT / investigator-led research explicitly disclosed

Full-service clinical Cross-border / multicentre trials Early-phase clinical Cell & gene therapy Data management & biostatistics Explicit IIT disclosure

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

IQVIA / KunTuo China ↗

Compare and save in the member map →

International CRO China operations

Parexel China

International full-service CRO with China delivery and published early-phase partner-site information. Confirm the actual team, indication and protocol rather than assuming global coverage establishes IIT fit.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Early-phase clinical

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Parexel China ↗ · Parexel China ↗

Compare and save in the member map →

International CRO China operations

ICON China

International CRO disclosing China/APAC clinical operations and a Beijing central laboratory. Contract clinical operations and laboratory scope separately; current IIT support is not established by the reviewed sources.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

ICON China ↗ · ICON China ↗

Compare and save in the member map →

International CRO China operations

PPD China (Thermo Fisher Scientific)

Thermo Fisher’s clinical research business. Its China page describes local regulatory, linguistic and operational support for development programs.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

PPD China (Thermo Fisher Scientific) ↗

Compare and save in the member map →

International CRO China operations

Fortrea China

International CRO with official China locations and a multinational oncology case study. A case example does not establish experience across every indication or IIT pathway.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Fortrea China ↗ · Fortrea China ↗

Compare and save in the member map →

International CRO China operations

Syneos Health China

International clinical development platform with officially listed Beijing and Shanghai offices. Assess integrated global delivery separately from local IIT scope and confirm current resources.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Syneos Health China ↗

Compare and save in the member map →

International CRO China operations

Medpace China

International full-service CRO with official evidence of Shanghai and Beijing clinical teams. Confirm current China full-service scope and IIT availability directly.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Oncology

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Medpace China ↗ · Medpace China ↗

Compare and save in the member map →

International CRO China operations

CMIC China

Japan-origin CRO whose China page describes Beijing operations, site selection and CRC support. Group physician-initiated research capability does not automatically establish China IIT delivery.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

CMIC China ↗ · CMIC China ↗

Compare and save in the member map →

International CRO China operations

EPS China / EPS International

Japan-origin EPS China CRO platform disclosing Phase I–IV, data, statistics, monitoring, regulatory and PV services. China affiliates are consolidated; confirm the actual contracting entity.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials Data management & biostatistics

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

EPS China / EPS International ↗ · EPS China / EPS International ↗

Compare and save in the member map →

International CRO China operations

Linical China

Japan-origin global CRO with China multilingual teams and clinical development disclosed on its APAC page. Confirm inbound China project scope and IIT services separately.

IIT evidence: IIT capability not established by reviewed sources

Full-service clinical Cross-border / multicentre trials

Confirm before selection

Confirm the contracting entity, English-speaking PM, recent international sponsor references and indication-specific site resources.
IIT eligibility, ethics, data access, HGR responsibilities and any intended overseas data use require a project-specific assessment.

Checked: 2026-11-06 · Based on public disclosure, not a quality audit.

Linical China ↗

Compare and save in the member map →

Partner-selection questions for international biotechs

Delivery team: who is the named English-speaking project manager, which China entity contracts, and which functions are subcontracted?
Relevant experience: request recent international sponsor references, indication/modality-matched case studies and named investigator/site availability.
IIT fit: agree the investigator and institution roles, study governance, scientific objective and intended downstream use of the data before selecting a pathway.
Quality and safety: review the quality system, audit history, monitoring plan, medical monitoring, PV and access to source records.
Data and cross-border use: agree ownership, English outputs, database specifications, HGR/data responsibilities and any proposed overseas submission use.
Execution and budget: compare site activation assumptions, recruitment feasibility, itemized costs, milestones, dependencies and change-control terms.

Use the directory for partner discovery and comparison. Investigators, institutions, sponsors and relevant professional teams must define the pathway and responsibilities for each study.